CA2948196C - Dentifrice compositions with improved fluoride stability - Google Patents
Dentifrice compositions with improved fluoride stability Download PDFInfo
- Publication number
- CA2948196C CA2948196C CA2948196A CA2948196A CA2948196C CA 2948196 C CA2948196 C CA 2948196C CA 2948196 A CA2948196 A CA 2948196A CA 2948196 A CA2948196 A CA 2948196A CA 2948196 C CA2948196 C CA 2948196C
- Authority
- CA
- Canada
- Prior art keywords
- composition
- weight
- carrageenan
- composition according
- alternatively
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 167
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 title claims abstract description 71
- 239000000551 dentifrice Substances 0.000 title claims abstract description 35
- 229920001525 carrageenan Polymers 0.000 claims abstract description 49
- 239000000679 carrageenan Substances 0.000 claims abstract description 42
- 229940113118 carrageenan Drugs 0.000 claims abstract description 42
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 29
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 18
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 32
- 229940091249 fluoride supplement Drugs 0.000 claims description 28
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 24
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000011575 calcium Substances 0.000 claims description 24
- 229910052791 calcium Inorganic materials 0.000 claims description 24
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 17
- 239000000377 silicon dioxide Substances 0.000 claims description 12
- 239000003906 humectant Substances 0.000 claims description 10
- 230000008719 thickening Effects 0.000 claims description 7
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000000600 sorbitol Substances 0.000 claims description 6
- 239000004094 surface-active agent Substances 0.000 claims description 6
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical group OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 claims description 5
- ZNOZWUKQPJXOIG-XSBHQQIPSA-L [(2r,3s,4r,5r,6s)-6-[[(1r,3s,4r,5r,8s)-3,4-dihydroxy-2,6-dioxabicyclo[3.2.1]octan-8-yl]oxy]-4-[[(1r,3r,4r,5r,8s)-8-[(2s,3r,4r,5r,6r)-3,4-dihydroxy-6-(hydroxymethyl)-5-sulfonatooxyoxan-2-yl]oxy-4-hydroxy-2,6-dioxabicyclo[3.2.1]octan-3-yl]oxy]-5-hydroxy-2-( Chemical compound O[C@@H]1[C@@H](O)[C@@H](OS([O-])(=O)=O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H]2OC[C@H]1O[C@H](O[C@H]1[C@H]([C@@H](CO)O[C@@H](O[C@@H]3[C@@H]4OC[C@H]3O[C@H](O)[C@@H]4O)[C@@H]1O)OS([O-])(=O)=O)[C@@H]2O ZNOZWUKQPJXOIG-XSBHQQIPSA-L 0.000 claims description 5
- 229960004711 sodium monofluorophosphate Drugs 0.000 claims description 5
- 239000003945 anionic surfactant Substances 0.000 claims description 4
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 3
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical group [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 3
- 235000011187 glycerol Nutrition 0.000 claims description 3
- 235000019333 sodium laurylsulphate Nutrition 0.000 claims description 3
- -1 sulfate ester Chemical class 0.000 claims description 3
- 210000003298 dental enamel Anatomy 0.000 claims description 2
- 229940088417 precipitated calcium carbonate Drugs 0.000 claims description 2
- RJLKGFBNQVLCPI-PIIYHDNRSA-N [(2r,3s,4s,5r)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl] hydrogen sulfate;[(2r,3s,4s,5r)-3,4,5-trihydroxy-1-oxo-6-sulfooxyhexan-2-yl] hydrogen sulfate Chemical compound OC[C@@H](O)[C@H](O)[C@H](O)[C@H](C=O)OS(O)(=O)=O.OS(=O)(=O)OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](OS(O)(=O)=O)C=O RJLKGFBNQVLCPI-PIIYHDNRSA-N 0.000 claims 1
- 238000009472 formulation Methods 0.000 abstract description 27
- 239000000243 solution Substances 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 13
- 239000002245 particle Substances 0.000 description 13
- 235000010216 calcium carbonate Nutrition 0.000 description 12
- 239000001768 carboxy methyl cellulose Substances 0.000 description 11
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 10
- 239000008367 deionised water Substances 0.000 description 10
- 229910021641 deionized water Inorganic materials 0.000 description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical class [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 9
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 9
- 230000008901 benefit Effects 0.000 description 8
- 239000002562 thickening agent Substances 0.000 description 8
- 239000002202 Polyethylene glycol Substances 0.000 description 7
- 238000009826 distribution Methods 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 229920001223 polyethylene glycol Polymers 0.000 description 7
- 229920001282 polysaccharide Polymers 0.000 description 7
- 239000005017 polysaccharide Substances 0.000 description 7
- FQENQNTWSFEDLI-UHFFFAOYSA-J sodium diphosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])(=O)OP([O-])([O-])=O FQENQNTWSFEDLI-UHFFFAOYSA-J 0.000 description 7
- 235000019818 tetrasodium diphosphate Nutrition 0.000 description 7
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 150000004676 glycans Chemical class 0.000 description 6
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 6
- 239000004033 plastic Substances 0.000 description 6
- 229920003023 plastic Polymers 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 238000003801 milling Methods 0.000 description 5
- 229940074371 monofluorophosphate Drugs 0.000 description 5
- 239000002002 slurry Substances 0.000 description 5
- 239000001488 sodium phosphate Substances 0.000 description 5
- 239000003765 sweetening agent Substances 0.000 description 5
- 235000019801 trisodium phosphate Nutrition 0.000 description 5
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 4
- 239000004593 Epoxy Substances 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 239000007979 citrate buffer Substances 0.000 description 4
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical class [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 4
- 235000019799 monosodium phosphate Nutrition 0.000 description 4
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 4
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 4
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical class [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003086 colorant Substances 0.000 description 3
- 150000002500 ions Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 235000011121 sodium hydroxide Nutrition 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000004408 titanium dioxide Substances 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000003082 abrasive agent Substances 0.000 description 2
- 230000002272 anti-calculus Effects 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical class OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 239000004075 cariostatic agent Substances 0.000 description 2
- 239000003093 cationic surfactant Substances 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000007865 diluting Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- NROKBHXJSPEDAR-UHFFFAOYSA-M potassium fluoride Chemical compound [F-].[K+] NROKBHXJSPEDAR-UHFFFAOYSA-M 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 239000012488 sample solution Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 2
- 239000001509 sodium citrate Substances 0.000 description 2
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 2
- 239000011775 sodium fluoride Substances 0.000 description 2
- 235000013024 sodium fluoride Nutrition 0.000 description 2
- 230000006641 stabilisation Effects 0.000 description 2
- 238000011105 stabilization Methods 0.000 description 2
- 238000010561 standard procedure Methods 0.000 description 2
- ANOBYBYXJXCGBS-UHFFFAOYSA-L stannous fluoride Chemical compound F[Sn]F ANOBYBYXJXCGBS-UHFFFAOYSA-L 0.000 description 2
- 229960002799 stannous fluoride Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 2
- BHHYHSUAOQUXJK-UHFFFAOYSA-L zinc fluoride Chemical compound F[Zn]F BHHYHSUAOQUXJK-UHFFFAOYSA-L 0.000 description 2
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Chemical class 0.000 description 1
- 239000004135 Bone phosphate Substances 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- 239000004132 Calcium polyphosphate Substances 0.000 description 1
- 230000010736 Chelating Activity Effects 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- 229930182827 D-tryptophan Natural products 0.000 description 1
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 235000019738 Limestone Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 239000004384 Neotame Substances 0.000 description 1
- BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
- 239000004115 Sodium Silicate Substances 0.000 description 1
- 241001479493 Sousa Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- YGCFIWIQZPHFLU-UHFFFAOYSA-N acesulfame Chemical compound CC1=CC(=O)NS(=O)(=O)O1 YGCFIWIQZPHFLU-UHFFFAOYSA-N 0.000 description 1
- 229960005164 acesulfame Drugs 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000007259 addition reaction Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 1
- 150000008041 alkali metal carbonates Chemical class 0.000 description 1
- 150000008044 alkali metal hydroxides Chemical class 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 230000000675 anti-caries Effects 0.000 description 1
- 238000000149 argon plasma sintering Methods 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 235000019827 calcium polyphosphate Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- FOCAUTSVDIKZOP-UHFFFAOYSA-N chloroacetic acid Chemical compound OC(=O)CCl FOCAUTSVDIKZOP-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000000368 destabilizing effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 235000019820 disodium diphosphate Nutrition 0.000 description 1
- GYQBBRRVRKFJRG-UHFFFAOYSA-L disodium pyrophosphate Chemical compound [Na+].[Na+].OP([O-])(=O)OP(O)([O-])=O GYQBBRRVRKFJRG-UHFFFAOYSA-L 0.000 description 1
- 229940038485 disodium pyrophosphate Drugs 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960002737 fructose Drugs 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 229960001031 glucose Drugs 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 238000010902 jet-milling Methods 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229960001375 lactose Drugs 0.000 description 1
- 239000006028 limestone Substances 0.000 description 1
- 239000012669 liquid formulation Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 229960002160 maltose Drugs 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 229940045641 monobasic sodium phosphate Drugs 0.000 description 1
- 235000019412 neotame Nutrition 0.000 description 1
- HLIAVLHNDJUHFG-HOTGVXAUSA-N neotame Chemical compound CC(C)(C)CCN[C@@H](CC(O)=O)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 HLIAVLHNDJUHFG-HOTGVXAUSA-N 0.000 description 1
- 108010070257 neotame Proteins 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 229960001245 olaflur Drugs 0.000 description 1
- ZVVSSOQAYNYNPP-UHFFFAOYSA-N olaflur Chemical compound F.F.CCCCCCCCCCCCCCCCCCN(CCO)CCCN(CCO)CCO ZVVSSOQAYNYNPP-UHFFFAOYSA-N 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 150000003867 organic ammonium compounds Chemical class 0.000 description 1
- 239000006179 pH buffering agent Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- 235000003270 potassium fluoride Nutrition 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical class [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Chemical class 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- NTHWMYGWWRZVTN-UHFFFAOYSA-N sodium silicate Chemical compound [Na+].[Na+].[O-][Si]([O-])=O NTHWMYGWWRZVTN-UHFFFAOYSA-N 0.000 description 1
- 229910052911 sodium silicate Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000012086 standard solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- 230000019635 sulfation Effects 0.000 description 1
- 238000005670 sulfation reaction Methods 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- CDVLCTOFEIEUDH-UHFFFAOYSA-K tetrasodium;phosphate Chemical compound [Na+].[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O CDVLCTOFEIEUDH-UHFFFAOYSA-K 0.000 description 1
- 229940078499 tricalcium phosphate Drugs 0.000 description 1
- 235000019731 tricalcium phosphate Nutrition 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 238000002525 ultrasonication Methods 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/24—Phosphorous; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
- A61K2800/28—Rubbing or scrubbing compositions; Peeling or abrasive compositions; Containing exfoliants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/48—Thickener, Thickening system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Cosmetics (AREA)
Abstract
Soluble fluoride ion stability is increased in certain dentifrice formulations with the use of carrageenan, particularly under alkaline pH conditions.
Description
DENTIFRICE COMPOSITIONS WITH IMPROVED FLUORIDE STABILITY
FIELD OF THE INVENTION
The present invention relates to dentifrice composition having a fluoride ion source.
BACKGROUND OF THE INVENTION
Dentifrice compositions are well known for dental and oral hygiene care. High water (e.g., >45 wt%) and high carbonate (e.g., >25 wt%) formulation chassis are a cost effective for many markets and consumers. The use of linear sulfated polysaccharide (e.g., carrageenan) has [0 been reported in dentifrice compositions as a thickening agent. However, this formulation chassis sometimes has fluoride ion stability issues that often exacerbated when there are high temperatures and/or long distribution times such as in some developing markets. Fluoride, and its associated benefits, is critical for a user's experience and product acceptance. There is a need to provide dentifrice formulations having improved fluoride ion stability.
[5 SUMMARY OF THE INVENTION
The present invention is based, in part, on the surprising observation that soluble fluoride ion stability is increased in high water and high carbonate dentifrice formulations with the use of carrageenan. Furthermore, this fluoride ion stability effect is further enhanced under pH
W conditions that are greater than pH 8, preferably greater than pH 8Ø
Yet still further, of the carrageenans, Lambda- carrageenan appears to be the best performing one for fluoride ion stability.
Accordingly, an advantage of the present invention is soluble fluoride stability over time.
The advantages are observed in accelerated high temperature (e.g., 60 C for 6 weeks) as well as long term ambient conditions (e.g., 30 C for 1 year).
One aspect of the invention provides for dentifrice composition comprising:
(a) 45% to 75%
water, preferably 50% to 60% water, by weight of the composition; (b) 25% to 50%, preferably 27% to 47%, preferably 27% to 37% of a calcium-containing abrasive by weight of the composition, preferably wherein the calcium-containing abrasive is calcium carbonate; (c) 30 0.0025% to 2%, preferably from 0.5% to 1.5% of a fluoride ion source by weight of the composition, preferably wherein the fluoride ion source is sodium monofluorophosphate; (d) 0.01%% to 7%, preferably from 0.1% to 6% of a linear sulfated polysaccharide by weight of the composition, preferably wherein the linear sulfated polysaccharide is a carrageenam and (e) pH
greater than 8.0, preferably greater than 8.5. more preferably at or greater than pH 9.
Another aspect of the invention provides a dentifrice composition comprising:
(a) 45% to 75%, preferably 50% to 60% water by weight of the composition; (b) 25% to 50%, preferably 27%
to 47%, preferably 27% to 37% of a calcium-containing abrasive by weight of the composition, preferably wherein the calcium-containing abrasive comprises calcium carbonate; (c) 0.0025% to
FIELD OF THE INVENTION
The present invention relates to dentifrice composition having a fluoride ion source.
BACKGROUND OF THE INVENTION
Dentifrice compositions are well known for dental and oral hygiene care. High water (e.g., >45 wt%) and high carbonate (e.g., >25 wt%) formulation chassis are a cost effective for many markets and consumers. The use of linear sulfated polysaccharide (e.g., carrageenan) has [0 been reported in dentifrice compositions as a thickening agent. However, this formulation chassis sometimes has fluoride ion stability issues that often exacerbated when there are high temperatures and/or long distribution times such as in some developing markets. Fluoride, and its associated benefits, is critical for a user's experience and product acceptance. There is a need to provide dentifrice formulations having improved fluoride ion stability.
[5 SUMMARY OF THE INVENTION
The present invention is based, in part, on the surprising observation that soluble fluoride ion stability is increased in high water and high carbonate dentifrice formulations with the use of carrageenan. Furthermore, this fluoride ion stability effect is further enhanced under pH
W conditions that are greater than pH 8, preferably greater than pH 8Ø
Yet still further, of the carrageenans, Lambda- carrageenan appears to be the best performing one for fluoride ion stability.
Accordingly, an advantage of the present invention is soluble fluoride stability over time.
The advantages are observed in accelerated high temperature (e.g., 60 C for 6 weeks) as well as long term ambient conditions (e.g., 30 C for 1 year).
One aspect of the invention provides for dentifrice composition comprising:
(a) 45% to 75%
water, preferably 50% to 60% water, by weight of the composition; (b) 25% to 50%, preferably 27% to 47%, preferably 27% to 37% of a calcium-containing abrasive by weight of the composition, preferably wherein the calcium-containing abrasive is calcium carbonate; (c) 30 0.0025% to 2%, preferably from 0.5% to 1.5% of a fluoride ion source by weight of the composition, preferably wherein the fluoride ion source is sodium monofluorophosphate; (d) 0.01%% to 7%, preferably from 0.1% to 6% of a linear sulfated polysaccharide by weight of the composition, preferably wherein the linear sulfated polysaccharide is a carrageenam and (e) pH
greater than 8.0, preferably greater than 8.5. more preferably at or greater than pH 9.
Another aspect of the invention provides a dentifrice composition comprising:
(a) 45% to 75%, preferably 50% to 60% water by weight of the composition; (b) 25% to 50%, preferably 27%
to 47%, preferably 27% to 37% of a calcium-containing abrasive by weight of the composition, preferably wherein the calcium-containing abrasive comprises calcium carbonate; (c) 0.0025% to
2%, preferably from 0.5% to 1.5% of a fluoride ion source by weight of the composition.
preferably the fluoride ion SOUSA: comprises sodium monolluorophosphate; and (d) 0.01% ic to 7%, preferably from 0.1% to 6% of a Lambda-carrageenan by weight of the composition.
1.0 Yet another aspect of the invention provides a method of treating tooth enamel comprising the step of brushing teeth with an oral care composition described herein.
While the specification concludes with claims that particularly point out and distinctly claim the invention, it is believed the present invention will be better understood from the following description.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 describes dentifrice formulations of Examples 1-15, wherein Examples 1, 12, 13, 14, and 15 are control formulations.
DETAILED DESCRIPTION OF THE INVENTION
Definitions The term "orally acceptable carrier" as used herein means a suitable vehicle or ingredient, which can be used to form and/or apply the present compositions to the oral cavity in a safe and effective manner.
?.5 The term "comprising" as used herein means that steps and ingredients other than those specifically mentioned can be added. This term encompasses the terms "consisting or' and "consisting essentially of." The compositions of the present invention can comprise, consist of, and consist essentially of the essential elements and limitations of the invention described herein, as well as any of the additional or optional ingredients, components, steps, or limitations described herein.
The term "effective amount" as used herein means an amount of a compound or composition sufficient to induce a positive benefit, an oral health benefit, and/or an amount low enough to avoid serious, side effects. i.e.. to provide a reasonable benefit to risk ratio, within the sound judgment of a skilled artisan. In one embodiment, "effective amount"
means at least 0.01%
of the material, by weight of the composition, alternatively at least 0.1%.
The term "dentifrice" as used herein means paste, gel, powder, tablets, or liquid formulations, unless otherwise specified, that are used to clean the surfaces of the oral cavity.
The term "teeth" as used herein refers to natural teeth as well as artificial teeth or dental prosthesis.
All percentages, parts and ratios are based upon the total weight of the compositions of the present invention, unless otherwise specified. All such weights as they pertain to listed ingredients are based on the active level and, therefore do not include solvents or by-products that may be included in commercially available materials, unless otherwise specified. The term "weight percent" may be denoted as "wt%" herein. All molecular weights as used herein are weight average molecular weights expressed as grams/mole, unless otherwise specified.
As used herein, the articles including -a" and "an" when used in a claim, are understood to mean one or more of what is claimed or described.
As used herein, the terms "comprise". "comprises", "comprising", "include", "includes", "including", "contain", "contains", and "containing" are meant to be non-limiting, i.e., other steps and other sections which do not affect the end of result can be added.
The above terms encompass the terms "consisting of' and "consisting essentially of'.
As used herein, the words "preferred", "preferably" and variants refer to embodiments of the invention that afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the invention.
Water !,5 The compositions of the present invention comprise herein from 45% to 75%, by weight of the composition of water. In one embodiment, the composition includes from 40%
to 70%, alternatively from 45% to 65%, alternatively from 40% to 60%, alternatively from 50% to 70%, alternatively from 50% to 60 %, alternatively from 45% to 55%, alternatively from 55% to 65%, alternatively from 50% to 60%, alternatively about 55%, alternatively combinations thereof, of water by weight of the composition. The water may be added to the formulation and/or may come into the composition from the inclusion of other ingredients. Preferably the water is USP
water.
Calcium-containing abrasive
preferably the fluoride ion SOUSA: comprises sodium monolluorophosphate; and (d) 0.01% ic to 7%, preferably from 0.1% to 6% of a Lambda-carrageenan by weight of the composition.
1.0 Yet another aspect of the invention provides a method of treating tooth enamel comprising the step of brushing teeth with an oral care composition described herein.
While the specification concludes with claims that particularly point out and distinctly claim the invention, it is believed the present invention will be better understood from the following description.
BRIEF DESCRIPTION OF THE DRAWINGS
Figure 1 describes dentifrice formulations of Examples 1-15, wherein Examples 1, 12, 13, 14, and 15 are control formulations.
DETAILED DESCRIPTION OF THE INVENTION
Definitions The term "orally acceptable carrier" as used herein means a suitable vehicle or ingredient, which can be used to form and/or apply the present compositions to the oral cavity in a safe and effective manner.
?.5 The term "comprising" as used herein means that steps and ingredients other than those specifically mentioned can be added. This term encompasses the terms "consisting or' and "consisting essentially of." The compositions of the present invention can comprise, consist of, and consist essentially of the essential elements and limitations of the invention described herein, as well as any of the additional or optional ingredients, components, steps, or limitations described herein.
The term "effective amount" as used herein means an amount of a compound or composition sufficient to induce a positive benefit, an oral health benefit, and/or an amount low enough to avoid serious, side effects. i.e.. to provide a reasonable benefit to risk ratio, within the sound judgment of a skilled artisan. In one embodiment, "effective amount"
means at least 0.01%
of the material, by weight of the composition, alternatively at least 0.1%.
The term "dentifrice" as used herein means paste, gel, powder, tablets, or liquid formulations, unless otherwise specified, that are used to clean the surfaces of the oral cavity.
The term "teeth" as used herein refers to natural teeth as well as artificial teeth or dental prosthesis.
All percentages, parts and ratios are based upon the total weight of the compositions of the present invention, unless otherwise specified. All such weights as they pertain to listed ingredients are based on the active level and, therefore do not include solvents or by-products that may be included in commercially available materials, unless otherwise specified. The term "weight percent" may be denoted as "wt%" herein. All molecular weights as used herein are weight average molecular weights expressed as grams/mole, unless otherwise specified.
As used herein, the articles including -a" and "an" when used in a claim, are understood to mean one or more of what is claimed or described.
As used herein, the terms "comprise". "comprises", "comprising", "include", "includes", "including", "contain", "contains", and "containing" are meant to be non-limiting, i.e., other steps and other sections which do not affect the end of result can be added.
The above terms encompass the terms "consisting of' and "consisting essentially of'.
As used herein, the words "preferred", "preferably" and variants refer to embodiments of the invention that afford certain benefits, under certain circumstances. However, other embodiments may also be preferred, under the same or other circumstances. Furthermore, the recitation of one or more preferred embodiments does not imply that other embodiments are not useful, and is not intended to exclude other embodiments from the scope of the invention.
Water !,5 The compositions of the present invention comprise herein from 45% to 75%, by weight of the composition of water. In one embodiment, the composition includes from 40%
to 70%, alternatively from 45% to 65%, alternatively from 40% to 60%, alternatively from 50% to 70%, alternatively from 50% to 60 %, alternatively from 45% to 55%, alternatively from 55% to 65%, alternatively from 50% to 60%, alternatively about 55%, alternatively combinations thereof, of water by weight of the composition. The water may be added to the formulation and/or may come into the composition from the inclusion of other ingredients. Preferably the water is USP
water.
Calcium-containing abrasive
3 The compositions of the present invention comprise from 25% to 50% by weight of a calcium-containing abrasive, wherein the calcium-containing abrasive is selected from the group consisting of calcium carbonate, dicalcium phosphate, tricalcium phosphate, calcium orthophosphate, calcium metaphosphate, calcium polyphosphate, calcium oxyapatite, sodium carbonate, and combinations thereof. In preferred embodiment, the composition comprises from 25% to 60%, more preferably from 25% to 50%, even more preferably from 25% to 40%, yet even more preferably from 26% to 39%, alternatively from 27% to 47%, alternatively from 27% to 37%, alternatively from 30% to 35%, alternatively from 30% to 34%, alternatively combinations thereof, of a calcium-containing abrasive by weight of the composition.
l0 In yet still a further preferred composition contains calcium-containing abrasive at the previously indicated weight percentage, wherein the calcium-containing abrasive is a calcium carbonate, and wherein the calcium carbonate has: a D50 particle size range from 2 microns to 7 microns, preferably from 3 microns to 6 microns, more preferably from 3.4 microns to 5.8 microns; or D90 from 8 microns to 15 microns, preferably from 9 microns to 14 microns, more preferably from 9.2 microns to 13.5 microns; or D98 range from less than 28 microns, preferably from 1 micron to less than 27 microns, more preferably less than 26 microns or from 1 micron to less than 26 microns. More preferably the calcium carbonate has a particle size range at the aforementioned D50 and D90 ranges; even more preferably at the aforementioned D50, D90 and D98 ranges. Surprisingly, it is believed that having calcium carbonate at these aforementioned particle size distribution ranges may increase fluoride stability benefits.
Fluoride stability may be measured as described in herein.; and generally in China's National Standard Method GB 8372-2008.
The term "D50" means, in particle size distribution measurements, the mass-median-diameter, considered to be the average particle size by mass. That is, the D50 is the size in )-5 microns that splits the distribution with half above and half below this diameter by mass. The term D90 similarly means the size in microns that splits 90 percent of the distribution below the D90 by mass. And the similarly the term D98 means the size in microns that 98 percent of the distribution below the D98 by mass.
The particle size of calcium carbonate (as a raw material) is measured by using a laser scattering particle sizing instrument (e.g., Bettersize BT9300H from DanDong Better Instrument, China). Generally, the laser scattering technique works by measuring the light diffracted from particulates as they pass through a laser beam. Particulates scatter light at an angle that is directly related to their size. Accordingly, the Bettersize BT9300H uses the light scattering
l0 In yet still a further preferred composition contains calcium-containing abrasive at the previously indicated weight percentage, wherein the calcium-containing abrasive is a calcium carbonate, and wherein the calcium carbonate has: a D50 particle size range from 2 microns to 7 microns, preferably from 3 microns to 6 microns, more preferably from 3.4 microns to 5.8 microns; or D90 from 8 microns to 15 microns, preferably from 9 microns to 14 microns, more preferably from 9.2 microns to 13.5 microns; or D98 range from less than 28 microns, preferably from 1 micron to less than 27 microns, more preferably less than 26 microns or from 1 micron to less than 26 microns. More preferably the calcium carbonate has a particle size range at the aforementioned D50 and D90 ranges; even more preferably at the aforementioned D50, D90 and D98 ranges. Surprisingly, it is believed that having calcium carbonate at these aforementioned particle size distribution ranges may increase fluoride stability benefits.
Fluoride stability may be measured as described in herein.; and generally in China's National Standard Method GB 8372-2008.
The term "D50" means, in particle size distribution measurements, the mass-median-diameter, considered to be the average particle size by mass. That is, the D50 is the size in )-5 microns that splits the distribution with half above and half below this diameter by mass. The term D90 similarly means the size in microns that splits 90 percent of the distribution below the D90 by mass. And the similarly the term D98 means the size in microns that 98 percent of the distribution below the D98 by mass.
The particle size of calcium carbonate (as a raw material) is measured by using a laser scattering particle sizing instrument (e.g., Bettersize BT9300H from DanDong Better Instrument, China). Generally, the laser scattering technique works by measuring the light diffracted from particulates as they pass through a laser beam. Particulates scatter light at an angle that is directly related to their size. Accordingly, the Bettersize BT9300H uses the light scattering
4 pattern associated with a sample to calculate particle size distributions. The methods of ISO
13320-1-1999 are followed. Briefly, calcium carbonate raw material is pre-dispersed in deionized water (DI-water"). And a volume of calcium carbonate slurry is transferred to sampling cell, which is filled with DI-water as dispersion solution. The particles of calcium .. carbonate are well dispersed by re-circulation and ultrasonication while particle size measurements are being obtained.
In one embodiment, the calcium-containing abrasive is calcium carbonate. In a preferred embodiment, the calcium-containing abrasive is selected from the group consisting of fine ground natural chalk, ground calcium carbonate, precipitated calcium carbonate, and [0 combinations thereof. In a more preferred embodiment, the calcium-containing abrasive is selected from fine ground natural chalk, ground calcium carbonate, and combinations thereof (at the aforementioned weight percentage ranges for calcium-containing abrasives;
and having the aforementioned D50, D90, and D98 measurements).
Fine ground natural chalk (FGNC) is one of the more preferred calcium-containing abrasives useful in the present invention. It is obtained from limestone or marble. FGNC may also be modified chemically or physically by coating during milling or after milling by heat treatment. Typical coating materials include magnesium stearate or oleate. The morphology of FGNC may also be modified during the milling process by using different milling techniques, for example, ball milling, air-classifier milling or spiral jet milling. One example of natural chalk is 10 described in WO 03/030850 having a medium particle size of 1 to 15 pm and a BET surface area of 0.5 to 3 m2/g. The natural calcium carbonate may have a particle size of 325 to 800 mesh, alternatively a mess selected from 325, 400 600, 800, or combinations thereof;
alternatively the particle size is from 0.1 to 30 microns, or from 0.1 to 20 microns, or from 5 to 20 microns In one embodiment, the composition of the present invention is free or substantially free of )-5 silicate.
PEG
The compositions of the present invention may comprise polyethylene glycol (PEG), of various weight percentages of the composition as well as various ranges of average molecular weights. In one aspect of the invention, the compositions have from 0.1% to 15%, preferably 30 from 0.2% to 12%, more preferably from 0.3% to 10%, yet more preferably from 0.5% to 7%, alternatively from 1% to 5%, alternatively from 1% to 4%, alternatively from 1% to 2%, alternatively from 2% to 3%, alternatively from 4% to 5%, or combinations thereof, of PEG by weight of the composition. In another aspect of the invention, the PEG is one having a range of
13320-1-1999 are followed. Briefly, calcium carbonate raw material is pre-dispersed in deionized water (DI-water"). And a volume of calcium carbonate slurry is transferred to sampling cell, which is filled with DI-water as dispersion solution. The particles of calcium .. carbonate are well dispersed by re-circulation and ultrasonication while particle size measurements are being obtained.
In one embodiment, the calcium-containing abrasive is calcium carbonate. In a preferred embodiment, the calcium-containing abrasive is selected from the group consisting of fine ground natural chalk, ground calcium carbonate, precipitated calcium carbonate, and [0 combinations thereof. In a more preferred embodiment, the calcium-containing abrasive is selected from fine ground natural chalk, ground calcium carbonate, and combinations thereof (at the aforementioned weight percentage ranges for calcium-containing abrasives;
and having the aforementioned D50, D90, and D98 measurements).
Fine ground natural chalk (FGNC) is one of the more preferred calcium-containing abrasives useful in the present invention. It is obtained from limestone or marble. FGNC may also be modified chemically or physically by coating during milling or after milling by heat treatment. Typical coating materials include magnesium stearate or oleate. The morphology of FGNC may also be modified during the milling process by using different milling techniques, for example, ball milling, air-classifier milling or spiral jet milling. One example of natural chalk is 10 described in WO 03/030850 having a medium particle size of 1 to 15 pm and a BET surface area of 0.5 to 3 m2/g. The natural calcium carbonate may have a particle size of 325 to 800 mesh, alternatively a mess selected from 325, 400 600, 800, or combinations thereof;
alternatively the particle size is from 0.1 to 30 microns, or from 0.1 to 20 microns, or from 5 to 20 microns In one embodiment, the composition of the present invention is free or substantially free of )-5 silicate.
PEG
The compositions of the present invention may comprise polyethylene glycol (PEG), of various weight percentages of the composition as well as various ranges of average molecular weights. In one aspect of the invention, the compositions have from 0.1% to 15%, preferably 30 from 0.2% to 12%, more preferably from 0.3% to 10%, yet more preferably from 0.5% to 7%, alternatively from 1% to 5%, alternatively from 1% to 4%, alternatively from 1% to 2%, alternatively from 2% to 3%, alternatively from 4% to 5%, or combinations thereof, of PEG by weight of the composition. In another aspect of the invention, the PEG is one having a range of
5 average molecular weight from 100 Daltons to 1600 Daltons, preferably from 200 to 1000, alternatively from 400 to 800, alternatively from 500 to 700 Daltons, alternatively combinations thereof. PEG is a water soluble linear polymer formed by the addition reaction of ethylene oxide to an ethylene glycol equivalent having the general formula is: H-(OCH2CH2)õ-OH. One supplier of PEG is Dow Chemical Company under the brand name of CARBOWAXTM.
Sweetener The oral care compositions herein may include a sweetening agent. These include sweeteners such as saccharin, dextrose, sucrose, lactose, maltose, levulose, aspartame, sodium cyclamate, D-tryptophan, dihydrochalcones, acesulfame, sucralose, neotame, and mixtures [0 thereof. Sweetening agents are generally used in oral compositions at levels of from 0.005% to 5%, by weight of the composition, alternatively 0.01% to 1%, alternatively from 0.1% to 0.5%, alternatively combinations thereof.
Fluoride ion source The compositions may include an effective amount of an anti-caries agent. In one embodiment, the anti-caries agent is a fluoride ion source. The fluoride ion may be present in an amount sufficient to give a fluoride ion concentration in the composition at 25 C. and/or in one embodiment can be used at levels of from about 0.0025% to about 5% by weight of the composition, alternatively from about 0.005% to about 2.0% by weight of the composition, to provide anti-caries effectiveness. Examples of suitable fluoride ion-yielding materials are 10 disclosed in U.S. Patent Nos. 3,535,421, and 3,678,154. Representative fluoride ion sources include: stannous fluoride, sodium fluoride, potassium fluoride, amine fluoride, sodium monofluorophosphate, and zinc fluoride. In one embodiment the dentifrice composition contains a fluoride source selected from stannous fluoride, sodium fluoride, and mixtures thereof. In one embodiment, the fluoride ion source is sodium monofluorophosphate, and wherein the )-5 composition comprises 0.0025% to 2% of the sodium monofluorophosphate by weight of the composition, alternatively from 0.5% to 1.5%, alternatively from 0.6% to 1.7%, alternatively combinations thereof. In another embodiment, the composition comprises from 0.0025% to 2%
of a fluoride ion source by weight of the composition.
PH
30 The pH of the dentifrice composition may be greater than pH 7.8, or from pH 8 to 13, more preferably from 9 to 12, alternatively greater than pH 8, alternatively greater than 9, alternatively from 9 to 11, alternatively from 9 to 10, or combinations thereof.
Sweetener The oral care compositions herein may include a sweetening agent. These include sweeteners such as saccharin, dextrose, sucrose, lactose, maltose, levulose, aspartame, sodium cyclamate, D-tryptophan, dihydrochalcones, acesulfame, sucralose, neotame, and mixtures [0 thereof. Sweetening agents are generally used in oral compositions at levels of from 0.005% to 5%, by weight of the composition, alternatively 0.01% to 1%, alternatively from 0.1% to 0.5%, alternatively combinations thereof.
Fluoride ion source The compositions may include an effective amount of an anti-caries agent. In one embodiment, the anti-caries agent is a fluoride ion source. The fluoride ion may be present in an amount sufficient to give a fluoride ion concentration in the composition at 25 C. and/or in one embodiment can be used at levels of from about 0.0025% to about 5% by weight of the composition, alternatively from about 0.005% to about 2.0% by weight of the composition, to provide anti-caries effectiveness. Examples of suitable fluoride ion-yielding materials are 10 disclosed in U.S. Patent Nos. 3,535,421, and 3,678,154. Representative fluoride ion sources include: stannous fluoride, sodium fluoride, potassium fluoride, amine fluoride, sodium monofluorophosphate, and zinc fluoride. In one embodiment the dentifrice composition contains a fluoride source selected from stannous fluoride, sodium fluoride, and mixtures thereof. In one embodiment, the fluoride ion source is sodium monofluorophosphate, and wherein the )-5 composition comprises 0.0025% to 2% of the sodium monofluorophosphate by weight of the composition, alternatively from 0.5% to 1.5%, alternatively from 0.6% to 1.7%, alternatively combinations thereof. In another embodiment, the composition comprises from 0.0025% to 2%
of a fluoride ion source by weight of the composition.
PH
30 The pH of the dentifrice composition may be greater than pH 7.8, or from pH 8 to 13, more preferably from 9 to 12, alternatively greater than pH 8, alternatively greater than 9, alternatively from 9 to 11, alternatively from 9 to 10, or combinations thereof.
6 A method for assessing pH of dentifrice is described. pH is measured by a pH
Meter with Automatic Temperature Compensating (ATC) probe. The pH Meter is capable of reading to 0.001 pH unit. The pH electrode may be selected from one of the following (i) Orion Ross Sure-Flow combination: Glass body - VWR #34104-834/Orion #8172BN or VWR#10010-772/Orion #8172BNWP; Epoxy body - VWR #34104-830/Orion #8165BN or VWR#10010-770/Orion #8165BNWP; Semi-micro, epoxy body - VWR #34104-837/Orion #8175BN or VWR#10010-774/Orion #3175BNWP; or (ii) Orion PerpHect combination:VWR #34104-843/Orion #8203BN
semi-micro, glass body; or (iii) suitable equivalent. The automatic temperature compensating probe is Fisher Scientific, Cat #13-620-16.
l0 A 25% by weight slurry of dentifrice is prepared with deionized water, and thereafter is centrifuged for 10 minutes at 15000 rotations-per-minute using a SORVALL RC
28S centrifuge and SS-34 rotor (or equivalent gravitational force, at 24149g force). The pH
is assessed in supernatant after one minute or the taking reading is stabilized. After each pH assessment, the electrode is washed with deionized water. Any excess water is wiped with a laboratory grade tissue. When not in issue, the electrode is kept immersed in a pH 7 buffer solution or an appropriate electrode storage solution.
pH modifying agent The dentifrice compositions herein may include an effective amount of a pH
modifying agent, alternatively wherein the pH modifying agent is a pH buffering agent.
pH modifying 10 agents, as used herein, refer to agents that can be used to adjust the pH of the dentifrice compositions to the above-identified pH range. pH modifying agents may include alkali metal hydroxides, ammonium hydroxide, organic ammonium compounds, carbonates, sesquicarbonates, borates, silicates, phosphates, imidazole, and mixtures thereof. Specific pH
agents include monosodium phosphate (monobasic sodium phosphate), trisodium phosphate (sodium phosphate !,5 tribasic dodecahydrate or "TSP"), sodium benzoate, benzoic acid, sodium hydroxide, potassium hydroxide, alkali metal carbonate salts, sodium carbonate, imidazole, pyrophosphate salts, sodium gluconate, lactic acid, sodium lactate, citric acid, sodium citrate, phosphoric acid. In one embodiment, 0.01% to 3%, preferably from 0.1% to 1% of TSP by weight of the composition, and 0.001% to 2%, preferably from 0.01% to 0.3% of monosodium phosphate by weight of the 30 composition is used. Without wishing to be bound by theory, TSP and monosodium phosphate may also have calcium ion chelating activity and therefore provide some monofluorophosphate stabilization (in those formulations containing monofluorophosphate).
Anti-calculus agent
Meter with Automatic Temperature Compensating (ATC) probe. The pH Meter is capable of reading to 0.001 pH unit. The pH electrode may be selected from one of the following (i) Orion Ross Sure-Flow combination: Glass body - VWR #34104-834/Orion #8172BN or VWR#10010-772/Orion #8172BNWP; Epoxy body - VWR #34104-830/Orion #8165BN or VWR#10010-770/Orion #8165BNWP; Semi-micro, epoxy body - VWR #34104-837/Orion #8175BN or VWR#10010-774/Orion #3175BNWP; or (ii) Orion PerpHect combination:VWR #34104-843/Orion #8203BN
semi-micro, glass body; or (iii) suitable equivalent. The automatic temperature compensating probe is Fisher Scientific, Cat #13-620-16.
l0 A 25% by weight slurry of dentifrice is prepared with deionized water, and thereafter is centrifuged for 10 minutes at 15000 rotations-per-minute using a SORVALL RC
28S centrifuge and SS-34 rotor (or equivalent gravitational force, at 24149g force). The pH
is assessed in supernatant after one minute or the taking reading is stabilized. After each pH assessment, the electrode is washed with deionized water. Any excess water is wiped with a laboratory grade tissue. When not in issue, the electrode is kept immersed in a pH 7 buffer solution or an appropriate electrode storage solution.
pH modifying agent The dentifrice compositions herein may include an effective amount of a pH
modifying agent, alternatively wherein the pH modifying agent is a pH buffering agent.
pH modifying 10 agents, as used herein, refer to agents that can be used to adjust the pH of the dentifrice compositions to the above-identified pH range. pH modifying agents may include alkali metal hydroxides, ammonium hydroxide, organic ammonium compounds, carbonates, sesquicarbonates, borates, silicates, phosphates, imidazole, and mixtures thereof. Specific pH
agents include monosodium phosphate (monobasic sodium phosphate), trisodium phosphate (sodium phosphate !,5 tribasic dodecahydrate or "TSP"), sodium benzoate, benzoic acid, sodium hydroxide, potassium hydroxide, alkali metal carbonate salts, sodium carbonate, imidazole, pyrophosphate salts, sodium gluconate, lactic acid, sodium lactate, citric acid, sodium citrate, phosphoric acid. In one embodiment, 0.01% to 3%, preferably from 0.1% to 1% of TSP by weight of the composition, and 0.001% to 2%, preferably from 0.01% to 0.3% of monosodium phosphate by weight of the 30 composition is used. Without wishing to be bound by theory, TSP and monosodium phosphate may also have calcium ion chelating activity and therefore provide some monofluorophosphate stabilization (in those formulations containing monofluorophosphate).
Anti-calculus agent
7 The dentifrice compositions may include an effective amount of an anti-calculus agent, which in one embodiment may be present from about 0.05% to about 50%, by weight of the composition, alternatively from about 0.05% to about 25%, alternatively from about 0.1% to about 15% by weight of the composition. Non-limiting examples include those described in US
2011/0104081 Al at paragraph 64, and those described in US 2012/0014883 Al at paragraphs 63 to 68, as well as the references cited therein. One example is a pyrophosphate salt as a source of pyrophosphate ion. In one embodiment, the composition comprises tetrasodium pyrophosphate (TSPP) or disodium pyrophosphate or combinations thereof, preferably 0.01% to 2%, more preferably from 0.1% to 1% of the pyrophosphate salt by weight of the composition. Without wishing to be bound by theory, TSPP may provide not only calcium chelating thereby mitigating plaque formation, but also may also provide the additional benefit of monofluorophosphate stabilization (in those formulations containing monofluorophosphate).
Surfactant The dentifrice compositions herein may include a surfactant. The surfactant may be selected from anionic, nonionic, amphoteric, zwitterionic, cationic surfactants, or mixtures thereof. The composition may include a surfactant at a level of from about 0.1% to about 10%, from about 0.025% to about 9%, from about 0.05% to about 5%, from about 0.1% to about 2.5%, from about 0.5% to about 2%, or from about 0.1% to about 1% by weight of the total composition. Non-limiting examples of anionic surfactants may include those described at US
2012/0082630 Al at 10 paragraphs 32, 33, 34, and 35. Non-limiting examples of zwitterionic or amphoteric surfactants may include those described at US 2012/0082630 Al at paragraph 36; cationic surfactants may include those described at paragraphs 37 of the reference; and nonionic surfactants may include those described at paragraph 38 of the reference. In one embodiment the composition comprises 0.1% to 5%, preferably 0.1% to 3%. alternatively from 0.3% to 3%, alternatively from 1.2% to )-5 2.4%, alternatively from 1.2% to 1.8%, alternatively from 1.5 % to 1.8%, alternatively combinations thereof, of the anionic surfactant sodium lauryl sulfate (SLS) by weight of the composition.
Thickening agent The dentifrice compositions herein may include one or more thickening agents.
A
30 thickening agent may be used in an amount from about 0.01% to about 15%, or from about 0.1%
to about 10%, or from about 0.1% to about 5%, by weight of the composition.
Non-limiting examples may include those described in US 2008/0081023 Al at paragraphs 134 to 137, and the references cited therein.
2011/0104081 Al at paragraph 64, and those described in US 2012/0014883 Al at paragraphs 63 to 68, as well as the references cited therein. One example is a pyrophosphate salt as a source of pyrophosphate ion. In one embodiment, the composition comprises tetrasodium pyrophosphate (TSPP) or disodium pyrophosphate or combinations thereof, preferably 0.01% to 2%, more preferably from 0.1% to 1% of the pyrophosphate salt by weight of the composition. Without wishing to be bound by theory, TSPP may provide not only calcium chelating thereby mitigating plaque formation, but also may also provide the additional benefit of monofluorophosphate stabilization (in those formulations containing monofluorophosphate).
Surfactant The dentifrice compositions herein may include a surfactant. The surfactant may be selected from anionic, nonionic, amphoteric, zwitterionic, cationic surfactants, or mixtures thereof. The composition may include a surfactant at a level of from about 0.1% to about 10%, from about 0.025% to about 9%, from about 0.05% to about 5%, from about 0.1% to about 2.5%, from about 0.5% to about 2%, or from about 0.1% to about 1% by weight of the total composition. Non-limiting examples of anionic surfactants may include those described at US
2012/0082630 Al at 10 paragraphs 32, 33, 34, and 35. Non-limiting examples of zwitterionic or amphoteric surfactants may include those described at US 2012/0082630 Al at paragraph 36; cationic surfactants may include those described at paragraphs 37 of the reference; and nonionic surfactants may include those described at paragraph 38 of the reference. In one embodiment the composition comprises 0.1% to 5%, preferably 0.1% to 3%. alternatively from 0.3% to 3%, alternatively from 1.2% to )-5 2.4%, alternatively from 1.2% to 1.8%, alternatively from 1.5 % to 1.8%, alternatively combinations thereof, of the anionic surfactant sodium lauryl sulfate (SLS) by weight of the composition.
Thickening agent The dentifrice compositions herein may include one or more thickening agents.
A
30 thickening agent may be used in an amount from about 0.01% to about 15%, or from about 0.1%
to about 10%, or from about 0.1% to about 5%, by weight of the composition.
Non-limiting examples may include those described in US 2008/0081023 Al at paragraphs 134 to 137, and the references cited therein.
8 In embodiment, the composition comprises a linear sulfated polysaccharide as a thickening agent. Carrageenans or carrageenins are one example of a linear sulfated polysaccharide.
Generally, carrageenans can vary based upon the degree of sulfation that include: Kappa-carrageenan, Iota-carrageenan, and Lambda-carrageenan. Combinations of carrageenans can be used. In one embodiment, the composition contains from 0.1% to 3% a linear sulfated polysaccharides by weight of the composition, preferably from 0.5% to 2%, alternatively from 0.6% to 1.8%, alternatively combinations thereof. In one embodiment, Iota-carrageenan is used.
In one embodiment, the composition comprises a silica agent, preferably a thickening silica obtained from sodium silicate solution by destabilizing with acid as to yield very fine particles.
[0 One commercially available example is ZEODENT branded silicas from Huber Engineered Materials (e.g., ZEODENT 103, 124, 113 115, 163, 165, 167). In one embodiment, the composition comprising from 0.5% to 5% by weight of the composition of a silica agent, preferably from 1% to 4%, alternatively from 1.5% to 3.5%, alternatively from 2% to 3%, alternatively from 2% to 5% alternatively from 1% to 3%, alternatively combinations thereof by weight of the composition.
In one embodiment, the composition comprises a carboxymethyl cellulose ("CMC"). CMC
is prepared from cellulose by treatment with alkali and monochloro-acetic acid or its sodium salt.
Different varieties are commercially characterized by viscosity. One commercially available example is AqualonTm branded CMC from Ashland Special Ingredients (e.g..
Aqualonlm 7H3SF;
AqualonTm 9M35F AqualonTm TM9A; Aqualonrm TM12A). In one embodiment, the composition contains from 0.1% to 3% of a CMC by weight of the composition, preferably from 0.5% to 2%, alternatively from 0.6% to 1.8%, alternatively combinations thereof by weight of the composition.
In yet another embodiment, the thickener agents may comprise liner sulfated polysaccharide )-5 (e.g., carrageenans), CMC, and preferably also a thickening silica for purposes of cost savings while achieving the right balancing of viscosity and elasticity.
In one embodiment, the composition comprises a thickener comprising: (a) 0.01% to less than 1.4 %, preferably from 0.1 %
to 1.3%, more preferably from 0.5% to 1.3% of a carrageenan by weight of the dentifrice composition; and (d) greater than 0.4 wt% to 2 wt%, preferably from 0.5% to 1.8%, more 30 preferably from 0.6% to 1.8% of a carboxymethyl cellulose (CMC) by weight of the dentifrice composition. In yet another embodiment, the aforementioned thickener further comprises 0.5%
to 5%, preferably 1% to 4%, of a thickening silica by weight of the dentifrice composition.
Low or Free Humectants
Generally, carrageenans can vary based upon the degree of sulfation that include: Kappa-carrageenan, Iota-carrageenan, and Lambda-carrageenan. Combinations of carrageenans can be used. In one embodiment, the composition contains from 0.1% to 3% a linear sulfated polysaccharides by weight of the composition, preferably from 0.5% to 2%, alternatively from 0.6% to 1.8%, alternatively combinations thereof. In one embodiment, Iota-carrageenan is used.
In one embodiment, the composition comprises a silica agent, preferably a thickening silica obtained from sodium silicate solution by destabilizing with acid as to yield very fine particles.
[0 One commercially available example is ZEODENT branded silicas from Huber Engineered Materials (e.g., ZEODENT 103, 124, 113 115, 163, 165, 167). In one embodiment, the composition comprising from 0.5% to 5% by weight of the composition of a silica agent, preferably from 1% to 4%, alternatively from 1.5% to 3.5%, alternatively from 2% to 3%, alternatively from 2% to 5% alternatively from 1% to 3%, alternatively combinations thereof by weight of the composition.
In one embodiment, the composition comprises a carboxymethyl cellulose ("CMC"). CMC
is prepared from cellulose by treatment with alkali and monochloro-acetic acid or its sodium salt.
Different varieties are commercially characterized by viscosity. One commercially available example is AqualonTm branded CMC from Ashland Special Ingredients (e.g..
Aqualonlm 7H3SF;
AqualonTm 9M35F AqualonTm TM9A; Aqualonrm TM12A). In one embodiment, the composition contains from 0.1% to 3% of a CMC by weight of the composition, preferably from 0.5% to 2%, alternatively from 0.6% to 1.8%, alternatively combinations thereof by weight of the composition.
In yet another embodiment, the thickener agents may comprise liner sulfated polysaccharide )-5 (e.g., carrageenans), CMC, and preferably also a thickening silica for purposes of cost savings while achieving the right balancing of viscosity and elasticity.
In one embodiment, the composition comprises a thickener comprising: (a) 0.01% to less than 1.4 %, preferably from 0.1 %
to 1.3%, more preferably from 0.5% to 1.3% of a carrageenan by weight of the dentifrice composition; and (d) greater than 0.4 wt% to 2 wt%, preferably from 0.5% to 1.8%, more 30 preferably from 0.6% to 1.8% of a carboxymethyl cellulose (CMC) by weight of the dentifrice composition. In yet another embodiment, the aforementioned thickener further comprises 0.5%
to 5%, preferably 1% to 4%, of a thickening silica by weight of the dentifrice composition.
Low or Free Humectants
9 WO 2015/172651 PCT/CN2015/(J77634 The compositions herein may be substantially free or free of humectants, alternatively contain low levels of humectanis. The term "humectant." for the purposes of present invention, include edible polyhydric alcohols such as glycerin, sorbitol. xylitol, butylene glycol. propylene glycol, and combinations thereof. In one embodiment, the humectant is selected from sorbitol, glycerin, and combinations thereof. In yet another embodiment, the humectant is sorbitol. In one embodiment, the composition comprises from 0% to less than 20% of humeetants by weight of the composition, preferably from 0% to 10%. alternatively from 0% to 5%, alternatively from 0% to 3%, alternatively from 0% to 2%, alternatively from 0% to 1%, alternatively less than 20%. or less than 19%, 18%, 15%, 12%. 8%, 7%, 6%, 4%, 3%, 2%, 1%, or less than 0.5%; or greater than 1%, or greater than 2%, 5%, 10%, or 15%; or combinations thereof, by weight of the composition. In yet another embodiment, the composition contains less than 20%
of sorbitol by weight of the composition.
In an alternative embodiment, the compositions of the present invention comprise a humectant, preferably from 1% to 13% by weight of the composition.
Colorant.
The compositions herein may include a colorant. Titanium dioxide is one example of a colorant. Titanium dioxide is a white powder which adds opacity to the compositions. Titanium dioxide generally can comprise from about 0.25% to about 5%, by weight of the composition.
Flavorant The compositions herein may include from about 0.001% to about 5%, alternatively from.
about 0.01% to about 4%, alternatively from about 0.1% to about 3%, alternatively from about 0.5% to about 2%, alternatively 1% to 1.5%, alternatively 0.5% to 1%, alternatively combinations thereof, of a flavorant composition by weight of the composition.
The term.
fla.vorant composition is used in the broadest sense to include flavor ingredients, or sensates. or Z5 sensate agents, or combinations thereof. Flavor ingredients may include those described in US
2012/0082630 Al at paragraph 39; and sensates and sensate ingredients may include those described at paragraphs 40 - 45. Excluded from the definition of composition is "sweetener" as described above).
DATA
Analytical Methods The method for assessing soluble fluoride is described consistent with the China's National Standard Method GB8372-2008. Briefly, an ion-selective electrode (ISE) is used to test soluble fluoride in dentifrice. An example, of a fluoride ion meter is SARTORIUS PP-50, but an to equivalent may be used. The ion meter may be fitted with a fluoride-specific ion electrode with a single-junction reference electrode by Orion Research Inc., Cat. No. 9609BNWP, but an equivalent may be used. The sample is prepared by using a balance that is accurate to the 0.0001 gram (g). 20 g of dentifrice is weighed into a tarred 50 mL plastic beaker and then gradually 50mL of deionized water is added, while a magnetic stir bar is stirring in the plastic beaker, until the dentifrice is a completely disperse solution. The entire solution is gently transferred to a 100mL plastic volumetric flask as to avoid generating foam (so the volume can be measured accurately), and deionized water is added to reach a total volume 100m1, and then the solution is shaken manually to form a slurry. The formed slurry is then transferred into
of sorbitol by weight of the composition.
In an alternative embodiment, the compositions of the present invention comprise a humectant, preferably from 1% to 13% by weight of the composition.
Colorant.
The compositions herein may include a colorant. Titanium dioxide is one example of a colorant. Titanium dioxide is a white powder which adds opacity to the compositions. Titanium dioxide generally can comprise from about 0.25% to about 5%, by weight of the composition.
Flavorant The compositions herein may include from about 0.001% to about 5%, alternatively from.
about 0.01% to about 4%, alternatively from about 0.1% to about 3%, alternatively from about 0.5% to about 2%, alternatively 1% to 1.5%, alternatively 0.5% to 1%, alternatively combinations thereof, of a flavorant composition by weight of the composition.
The term.
fla.vorant composition is used in the broadest sense to include flavor ingredients, or sensates. or Z5 sensate agents, or combinations thereof. Flavor ingredients may include those described in US
2012/0082630 Al at paragraph 39; and sensates and sensate ingredients may include those described at paragraphs 40 - 45. Excluded from the definition of composition is "sweetener" as described above).
DATA
Analytical Methods The method for assessing soluble fluoride is described consistent with the China's National Standard Method GB8372-2008. Briefly, an ion-selective electrode (ISE) is used to test soluble fluoride in dentifrice. An example, of a fluoride ion meter is SARTORIUS PP-50, but an to equivalent may be used. The ion meter may be fitted with a fluoride-specific ion electrode with a single-junction reference electrode by Orion Research Inc., Cat. No. 9609BNWP, but an equivalent may be used. The sample is prepared by using a balance that is accurate to the 0.0001 gram (g). 20 g of dentifrice is weighed into a tarred 50 mL plastic beaker and then gradually 50mL of deionized water is added, while a magnetic stir bar is stirring in the plastic beaker, until the dentifrice is a completely disperse solution. The entire solution is gently transferred to a 100mL plastic volumetric flask as to avoid generating foam (so the volume can be measured accurately), and deionized water is added to reach a total volume 100m1, and then the solution is shaken manually to form a slurry. The formed slurry is then transferred into
10 mL centrifuge [0 tubes, and centrifuged for 10 minutes at 15000 rotations-per-minute (RPM) (at 24149g force) at ambient temperature. Thereafter 0.5 mL of supernatant is transferred into a 2 mL mini-centrifugal tube, and 0.7 mL of 4 mon HC1 is added to the tub. Then the tub is capped, heated in a 50 C water bath for 10 minutes. Thereafter the contents of the tub are transferred to a 50 mL measuring flask. The following are also added to the flask: 0.7 mL of 4 mol/L NaOH to neutralize the solution; 5 mL of citrate buffer solution (described further below); deionized water is added until a total volume of 50 mL is achieved in the flask; and then the sample solution is gently mixed. The aforementioned citrate buffer solution is prepared by dissolving 100 g of sodium citrate, 60 mL of glacial acetic acid, 60 g of NaCl, and 30g of NaOH, all with water, adjusting the pH to 5.0-5.5, and diluting the citrate buffer solution with deionized water until a total volume of 1000 mL is achieved. Turning back to the sample solution, the entire 50 mL
solution is transferred to a 50 mL plastic beaker and the fluoride level is assessed based on a fluoride standard curve using the fluoride ion meter and electrode described.
The standard fluoride curve (w/w %) is prepared by accurately measuring 0.5 mL, 1.0 mL, 1.5 mL, 2.0 mL, and 2.5 mL fluoride ion standard solutions (100 mg/kg) into five respective 50 !,5 mL
plastic measuring flasks. 5mL of citrate buffer solution (made as previously described above) into each respective flask, and then diluting each solution to the scale with deionized water.
Thereafter, each solution is transferred into a 50 mL plastic beaker respectively, measuring potential E under magnetic agitation, recording potential values, and drawing E-logc (wherein "c"
is a concentration) standard curve.
method for assessing pH of dentifrice is described. pH is measured by a pH
Meter with Automatic Temperature Compensating (ATC) probe. The pH Meter is capable of reading to 0.001 pH unit. The pH electrode may be selected from one of the following (i) Orion Ross Sure-Flow combination: Glass body - VWR #34104-834/Orion #8172BN or VWR#10010-772/Orion
solution is transferred to a 50 mL plastic beaker and the fluoride level is assessed based on a fluoride standard curve using the fluoride ion meter and electrode described.
The standard fluoride curve (w/w %) is prepared by accurately measuring 0.5 mL, 1.0 mL, 1.5 mL, 2.0 mL, and 2.5 mL fluoride ion standard solutions (100 mg/kg) into five respective 50 !,5 mL
plastic measuring flasks. 5mL of citrate buffer solution (made as previously described above) into each respective flask, and then diluting each solution to the scale with deionized water.
Thereafter, each solution is transferred into a 50 mL plastic beaker respectively, measuring potential E under magnetic agitation, recording potential values, and drawing E-logc (wherein "c"
is a concentration) standard curve.
method for assessing pH of dentifrice is described. pH is measured by a pH
Meter with Automatic Temperature Compensating (ATC) probe. The pH Meter is capable of reading to 0.001 pH unit. The pH electrode may be selected from one of the following (i) Orion Ross Sure-Flow combination: Glass body - VWR #34104-834/Orion #8172BN or VWR#10010-772/Orion
11 #8172BNWP; Epoxy body - VWR #34104-830/Orion #8165BN or VWR#10010-770/Orion #8165BNWP; Semi-micro, epoxy body - VWR #34104-837/Orion #8175BN or VWR#10010-774/Orion #3175BNWP; or (ii) Orion PerpHect combination:VWR #34104-843/Orion #8203BN
semi-micro, glass body; or (iii) suitable equivalent. The automatic temperature compensating probe is Fisher Scientific, Cat #13-620-16.
A 25% by weight slurry of dentifrice is prepared with deionized water, and thereafter is centrifuged for 10 minutes at 15000 rotations-per-minute using a SORVALL RC
28S centrifuge and SS-34 rotor (or equivalent gravitational force, at 24149g force). The pH
is assessed in supernatant after one minute or the taking reading is stabilized. After each pH assessment, the l0 electrode is washed with deionized water. Any excess water is wiped with a laboratory grade tissue. When not in issue. the electrode is kept immersed in a pH 7 buffer solution or an appropriate electrode storage solution.
Fig. 1 describes dentifrice formulations of Examples 1 ¨ 15. In turn, the examples provide the data summarizes in Table 1-5 below.
Table 1 below demonstrates that the higher amount of carrageenan that is used in the described formulations of examples 1-5, the better soluble fluoride ion stability after being aged at 6 weeks at 60 C. The relatively high temperature is used to exacerbate any fluoride instability over time. Examples 1-5, as described by the formulations of Figure 1, are briefly summarized.
Examples 2-5 notable contain varying amounts of Iota-carrageenan (0.4 wt% to 2 wt%). except 10 Control E (i.e., Example 1) which does not contain any carrageenan.
Examples 1-5 contain the humectant Sorbitol at 17 wt%. Examples 1-3 contain sodium carboxymethyl cellulose while examples 4 and 5 do not. Examples 1-4 contain thickening silica while example 5 does not.
Table 1:
Soluble Soluble Fluoride Soluble Fluoride Iota-C arra-Example Fluoride (ppm, Drop (ppm, geenan (wt% ) (ppm, Day 1) 60 C/6 weeks) 60 C/6 weeks) 2 0.4 1326 433 893 3 0.8 1348 637 711 4 1.3 1360 712 648
semi-micro, glass body; or (iii) suitable equivalent. The automatic temperature compensating probe is Fisher Scientific, Cat #13-620-16.
A 25% by weight slurry of dentifrice is prepared with deionized water, and thereafter is centrifuged for 10 minutes at 15000 rotations-per-minute using a SORVALL RC
28S centrifuge and SS-34 rotor (or equivalent gravitational force, at 24149g force). The pH
is assessed in supernatant after one minute or the taking reading is stabilized. After each pH assessment, the l0 electrode is washed with deionized water. Any excess water is wiped with a laboratory grade tissue. When not in issue. the electrode is kept immersed in a pH 7 buffer solution or an appropriate electrode storage solution.
Fig. 1 describes dentifrice formulations of Examples 1 ¨ 15. In turn, the examples provide the data summarizes in Table 1-5 below.
Table 1 below demonstrates that the higher amount of carrageenan that is used in the described formulations of examples 1-5, the better soluble fluoride ion stability after being aged at 6 weeks at 60 C. The relatively high temperature is used to exacerbate any fluoride instability over time. Examples 1-5, as described by the formulations of Figure 1, are briefly summarized.
Examples 2-5 notable contain varying amounts of Iota-carrageenan (0.4 wt% to 2 wt%). except 10 Control E (i.e., Example 1) which does not contain any carrageenan.
Examples 1-5 contain the humectant Sorbitol at 17 wt%. Examples 1-3 contain sodium carboxymethyl cellulose while examples 4 and 5 do not. Examples 1-4 contain thickening silica while example 5 does not.
Table 1:
Soluble Soluble Fluoride Soluble Fluoride Iota-C arra-Example Fluoride (ppm, Drop (ppm, geenan (wt% ) (ppm, Day 1) 60 C/6 weeks) 60 C/6 weeks) 2 0.4 1326 433 893 3 0.8 1348 637 711 4 1.3 1360 712 648
12 Referring to Table 1 above, the lowest soluble fluoride drop on a parts per million (ppm) basis (column furthest on the right) is demonstrated by Example 5 by having 2 wt% of Iota-carrageenan having only a ppm drop value of 527. The lower the soluble fluoride ion drop, the more stable the formulation. Example 5 had the highest amount of Iota-carrageenan between the five examples and therefore demonstrated the best soluble fluoride ion stability among the five formulations. Control E (example 1) had the poorest soluble fluoride stability at 910 ppm.
The increasing amount of Iota- carrageenan of examples 2, 3, and 4 (i.e., 0.4, 0.8, and 1.3 wt%, respectively) demonstrated increasing soluble fluoride ion stability as evidenced by soluble fluoride ion drop ppm values of 893, 711, and 648 respectively. In sum, Table 1 suggests the l0 more carrageenan, the more soluble fluoride ion stable the formulation.
Table 2 below demonstrates that Lambda-carrageenan is the best between the three carrageenans in demonstrating fluoride ion stability on an equal weight basis.
Examples 6-10, as described by the formulations of Figure 1, are briefly summarized. Examples 6, 7, and 8 have increasing weight percentages (wt%) of Iota-Carrageen at 1 wt%, 2 wt%, and 3 wt%, respectively. Example 9 has Kappa-carrageenan type at 2 wt% and Example 10 at Lambda-carrageenan type at 2 wt%.
Table 2:
Carrageenan Soluble Soluble Fluoride Soluble Fluoride Example type Fluoride (ppm, Drop (ppm, (%w/w) (ppm, Day 1) 60 C/6 weeks) 60 C/6 weeks) 6 Iota/ 1 1311 300 1011 7 Iota/2 1228 400 828 8 Iota/3 1148 400 748 9 Kappa/ 2 1347 300 1047 10 Lambda/ 2, 1271 600 671 Referring to Table 2 above, the lowest soluble fluoride drop on a ppm basis (column furthest 10 on the right) is demonstrated by Example 10 by having 2 wt% of Lambda-carrageenan having only a ppm drop value of 671. Examples 7, 8, and 10 all have equal amounts (2 wt%) of each respective carrageenan type. Lambda- carrageenan (example 10) is the most effective for soluble fluoride ion stability, while Kappa- carrageenan (example 9) is the least effective at 1047.
Notably, the increasing amount of Iota- carrageenan of examples 6, 7, and 8 respectively, show
The increasing amount of Iota- carrageenan of examples 2, 3, and 4 (i.e., 0.4, 0.8, and 1.3 wt%, respectively) demonstrated increasing soluble fluoride ion stability as evidenced by soluble fluoride ion drop ppm values of 893, 711, and 648 respectively. In sum, Table 1 suggests the l0 more carrageenan, the more soluble fluoride ion stable the formulation.
Table 2 below demonstrates that Lambda-carrageenan is the best between the three carrageenans in demonstrating fluoride ion stability on an equal weight basis.
Examples 6-10, as described by the formulations of Figure 1, are briefly summarized. Examples 6, 7, and 8 have increasing weight percentages (wt%) of Iota-Carrageen at 1 wt%, 2 wt%, and 3 wt%, respectively. Example 9 has Kappa-carrageenan type at 2 wt% and Example 10 at Lambda-carrageenan type at 2 wt%.
Table 2:
Carrageenan Soluble Soluble Fluoride Soluble Fluoride Example type Fluoride (ppm, Drop (ppm, (%w/w) (ppm, Day 1) 60 C/6 weeks) 60 C/6 weeks) 6 Iota/ 1 1311 300 1011 7 Iota/2 1228 400 828 8 Iota/3 1148 400 748 9 Kappa/ 2 1347 300 1047 10 Lambda/ 2, 1271 600 671 Referring to Table 2 above, the lowest soluble fluoride drop on a ppm basis (column furthest 10 on the right) is demonstrated by Example 10 by having 2 wt% of Lambda-carrageenan having only a ppm drop value of 671. Examples 7, 8, and 10 all have equal amounts (2 wt%) of each respective carrageenan type. Lambda- carrageenan (example 10) is the most effective for soluble fluoride ion stability, while Kappa- carrageenan (example 9) is the least effective at 1047.
Notably, the increasing amount of Iota- carrageenan of examples 6, 7, and 8 respectively, show
13 increasing amount of soluble fluoride ion stability (evidenced by the lower ppm drops of 1011, 828, and 749, respectively).
Table 3 below demonstrates that a carrageenan containing dentifrice formulation is better at fluoride ion stability than two control formulations. Examples 11, 12, and 13, as described by the formulations of Figure 1, are briefly summarized. Example 11 contains Iota-carrageenan at 1.4 wt%. Control A (Example 12) and Control B (Example 13) formulations do not have any carrageenan. Control A and Control B formulations both have slightly more sodium carboxymethyl cellulose (CMC) and thickening silica than Example 11, but notably Control B
also has tetra sodium pyrophosphate (TSPP).
[0 Table 3:
Soluble Fluoride drop (ppm) Example Formula difference: 60 C 4 weeks 60 C 6 weeks 30 C 52 weeks 11 Iota-carrageenan (1.4 wt%) 530 830 330 No Carrageenan 12 Tetrasodium Pyro- 888 988 688 phosphate Tetrasodium Pyro-13 phosphate 676 876 376 No Carragcenan Referring to Table 3, the data takes into account possible fluoride ion stability effects of CMC, silica, and TSP. Given the lower soluble fluoride ion drop (ppm) of carrageenan-containing Example 11 at 4 weeks and 6 weeks at 60 C, as well as 30 C for about one year, [5 indicates that the carrageenan is providing improved fluoride ion stability in the described formulation as compared the control formulations. Example 12 does not contain carrageenan, but does contain tetrasodium pyrophosphate (TSPP).
Table 4 below demonstrates that a pH greater than 8.0 provides better fluoride ion stability in the dentifrice formulations described herein. Examples 11, 14, and 15, as described by the W formulations of Figure 1, are briefly summarized. Example 11 is at pH 9.4 and contains 1.414 wt%
of Iota-carrageenan, and also notably contains CMC and silica. Control C
(Example 14) and Control D (Example 15) formulations are at a lower pH of 7.8 and 8.3, respectively. Controls C
and D both also contain Iota-carrageenan at 2 wt% and 1.4 wt%, respectively.
The weight percentages of silica, saccharine, and monofluorophosphate slightly of Controls C and D differ
Table 3 below demonstrates that a carrageenan containing dentifrice formulation is better at fluoride ion stability than two control formulations. Examples 11, 12, and 13, as described by the formulations of Figure 1, are briefly summarized. Example 11 contains Iota-carrageenan at 1.4 wt%. Control A (Example 12) and Control B (Example 13) formulations do not have any carrageenan. Control A and Control B formulations both have slightly more sodium carboxymethyl cellulose (CMC) and thickening silica than Example 11, but notably Control B
also has tetra sodium pyrophosphate (TSPP).
[0 Table 3:
Soluble Fluoride drop (ppm) Example Formula difference: 60 C 4 weeks 60 C 6 weeks 30 C 52 weeks 11 Iota-carrageenan (1.4 wt%) 530 830 330 No Carrageenan 12 Tetrasodium Pyro- 888 988 688 phosphate Tetrasodium Pyro-13 phosphate 676 876 376 No Carragcenan Referring to Table 3, the data takes into account possible fluoride ion stability effects of CMC, silica, and TSP. Given the lower soluble fluoride ion drop (ppm) of carrageenan-containing Example 11 at 4 weeks and 6 weeks at 60 C, as well as 30 C for about one year, [5 indicates that the carrageenan is providing improved fluoride ion stability in the described formulation as compared the control formulations. Example 12 does not contain carrageenan, but does contain tetrasodium pyrophosphate (TSPP).
Table 4 below demonstrates that a pH greater than 8.0 provides better fluoride ion stability in the dentifrice formulations described herein. Examples 11, 14, and 15, as described by the W formulations of Figure 1, are briefly summarized. Example 11 is at pH 9.4 and contains 1.414 wt%
of Iota-carrageenan, and also notably contains CMC and silica. Control C
(Example 14) and Control D (Example 15) formulations are at a lower pH of 7.8 and 8.3, respectively. Controls C
and D both also contain Iota-carrageenan at 2 wt% and 1.4 wt%, respectively.
The weight percentages of silica, saccharine, and monofluorophosphate slightly of Controls C and D differ
14 WO 2015/172651. PCT/CN2015/077634 from Example 11. Compared to example II, Control C and D also has a lower level of calcium.
carbonate (25 wt% vs, 42 wt%) and higher level of water (65.32 wt% v. 48.96 wt%).
Table 4:
Soluble Soluble Fluoride Soluble Fluoride Soluble pH Fluoride (ppm, 60 C. Drop Fluoride drop Ex. percentage (ppm, Day I) 4 weeks) (ppm vs Day 1) (vs Day 1) 11. 9.4 1130 600 530 47%
14 7.8 850 340 510 60%
carbonate (25 wt% vs, 42 wt%) and higher level of water (65.32 wt% v. 48.96 wt%).
Table 4:
Soluble Soluble Fluoride Soluble Fluoride Soluble pH Fluoride (ppm, 60 C. Drop Fluoride drop Ex. percentage (ppm, Day I) 4 weeks) (ppm vs Day 1) (vs Day 1) 11. 9.4 1130 600 530 47%
14 7.8 850 340 510 60%
15 8.3 860 360 500 58%
Referring to Table 4, of the three lota-carrageenan containing samples.
Example 11 has the best fluoride ion stability effects at 4 weeks at. 60 C having the highest pH. of 9.4 by having a soluble fluoride ion drop of 47% compared to Controls C and D which had much higher drop percentage at60% and 58% . respectively. Therefore, the data suggests that pH
8.3 is better than 7.8, and pH 9.4 is better than 8.3 when it comes to fluoride ion stability.
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead. unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as "40 mm" is intended to mean "about 40 mm."
The citation of any document is not an admission that it is prior art with respect to any 10 invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches. suggests or discloses any such invention.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
Referring to Table 4, of the three lota-carrageenan containing samples.
Example 11 has the best fluoride ion stability effects at 4 weeks at. 60 C having the highest pH. of 9.4 by having a soluble fluoride ion drop of 47% compared to Controls C and D which had much higher drop percentage at60% and 58% . respectively. Therefore, the data suggests that pH
8.3 is better than 7.8, and pH 9.4 is better than 8.3 when it comes to fluoride ion stability.
The dimensions and values disclosed herein are not to be understood as being strictly limited to the exact numerical values recited. Instead. unless otherwise specified, each such dimension is intended to mean both the recited value and a functionally equivalent range surrounding that value. For example, a dimension disclosed as "40 mm" is intended to mean "about 40 mm."
The citation of any document is not an admission that it is prior art with respect to any 10 invention disclosed or claimed herein or that it alone, or in any combination with any other reference or references, teaches. suggests or discloses any such invention.
While particular embodiments of the present invention have been illustrated and described, it would be obvious to those skilled in the art that various other changes and modifications can be made without departing from the spirit and scope of the invention. It is therefore intended to cover in the appended claims all such changes and modifications that are within the scope of this invention.
16
Claims (21)
1. A dentifrice composition comprising:
(a) 45% to 75% of USP water by weight of the composition;
(b) 25% to 50% of a calcium-containing abrasive by weight of the composition;
(c) 0.0025% to 2% of a fluoride ion source by weight of the composition;
(d) 0.01% to 7% of a carrageenan by weight of the composition;
(e) pH greater than 8; and wherein the composition does not comprise thickening silica, and wherein the composition has a soluble fluoride drop of less than or equal to 600 ppm after 4 weeks at 60 °C.
(a) 45% to 75% of USP water by weight of the composition;
(b) 25% to 50% of a calcium-containing abrasive by weight of the composition;
(c) 0.0025% to 2% of a fluoride ion source by weight of the composition;
(d) 0.01% to 7% of a carrageenan by weight of the composition;
(e) pH greater than 8; and wherein the composition does not comprise thickening silica, and wherein the composition has a soluble fluoride drop of less than or equal to 600 ppm after 4 weeks at 60 °C.
2. The composition according to claim 1, wherein the pH is greater than 8.5.
3. The composition of claim 1 or 2, wherein the carrageenan is Kappa-carrageenan, Iota-carrageenan, or Lambda-carrageenan.
4. The composition according to any one of claims 1 to 3, wherein the water is 50% to 60%
by weight of the composition.
by weight of the composition.
5. The composition according to any one of claims 1 to 4, wherein the calcium-containing abrasive comprises calcium carbonate.
6. The composition according to any one of claims 1 to 5, wherein the calcium-containing abrasive is 27% to 37% by weight of the composition.
7. The composition according to any one of claims 1 to 6, wherein the composition further comprises 0.1% to 12% of a surfactant by weight of the composition.
8. The composition according to any one of claims 1 to 7, wherein the fluoride ion source is sodium monofluorophosphate.
9. The composition according to any one of claims 1 to 8, wherein the composition further comprises a humectant.
10. A dentifrice composition comprising:
(a) 45% to 75% of USP water by weight of the composition;
(b) 25% to 50% of a calcium-containing abrasive by weight of the composition;
(c) 0.0025% to 2% of a fluoride ion source by weight of the composition;
(d) 0.01% to 7% of a Lambda-carrageenan by weight of the composition; and (e) wherein the composition does not comprise thickening silica.
(a) 45% to 75% of USP water by weight of the composition;
(b) 25% to 50% of a calcium-containing abrasive by weight of the composition;
(c) 0.0025% to 2% of a fluoride ion source by weight of the composition;
(d) 0.01% to 7% of a Lambda-carrageenan by weight of the composition; and (e) wherein the composition does not comprise thickening silica.
11. The composition of claim 10, wherein the Lambda-carrageenan has a repeating unit of D-galactose-2-sulfate-D-galactose-2,6-disulfate providing a sulfate ester content from 30% to 40%
by weight of the Lambda-carrageenan.
by weight of the Lambda-carrageenan.
12. The composition of claim 10 or 11, wherein the pH is greater than 8.
13. The composition of claim 10, 11, or 12, wherein the calcium-containing abrasive comprises calcium carbonate.
14. The composition according to claim 1 or 2, wherein the composition comprises 0.1% to 6% of the carrageenan by weight of the composition.
15. The composition according to claim 5, wherein the calcium carbonate is fine ground natural chalk, ground calcium carbonate, precipitated calcium carbonate, and combinations thereof.
16. The composition according to claim 15, wherein the calcium carbonate is selected from fine ground natural chalk, ground calcium carbonate, or combinations thereof.
17. The composition according to claim 7, wherein the surfactant is an anionic surfactant.
18. The composition according to claim 17, wherein the anionic surfactant is sodium lauryl sulfate.
19. The composition according to claim 9, wherein the composition comprises 1% to 20% or 1% to 10% of the humectant by weight of the composition.
20. The composition according to claim 9 or 19, wherein the humectant is glycerin, sorbitol, or combinations thereof.
21. Use of the dentifrice composition according to any one of claims 1 to 20 for treating tooth enamel.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNPCT/CN2014/077529 | 2014-05-15 | ||
PCT/CN2014/077529 WO2015172344A1 (en) | 2014-05-15 | 2014-05-15 | Dentifrice compositions with improved fluoride stability |
PCT/CN2015/077634 WO2015172651A1 (en) | 2014-05-15 | 2015-04-28 | Dentifrice compositions with improved fluoride stability |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2948196A1 CA2948196A1 (en) | 2015-11-19 |
CA2948196C true CA2948196C (en) | 2019-07-09 |
Family
ID=54479164
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA2948196A Active CA2948196C (en) | 2014-05-15 | 2015-04-28 | Dentifrice compositions with improved fluoride stability |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP3142630A1 (en) |
CN (1) | CN106456462A (en) |
AR (1) | AR100467A1 (en) |
AU (1) | AU2015258611B2 (en) |
BR (1) | BR112016025826B1 (en) |
CA (1) | CA2948196C (en) |
MX (1) | MX363625B (en) |
WO (2) | WO2015172344A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112018008065B1 (en) * | 2015-11-13 | 2021-06-08 | The Procter & Gamble Company | toothpaste compositions with improved consumer experience |
WO2017079954A1 (en) | 2015-11-13 | 2017-05-18 | The Procter & Gamble Company | Dentifrice compositions with improved fluoride stability |
CN109475487A (en) * | 2016-07-15 | 2019-03-15 | 宝洁公司 | The method for being used to prepare oral care composition |
EP4387586A1 (en) * | 2021-08-19 | 2024-06-26 | Unilever IP Holdings B.V. | Oral care composition comprising iota carrageenan and kappa carrageenan |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8927073D0 (en) * | 1989-11-30 | 1990-01-31 | Unilever Plc | Oral compositions |
AU2612999A (en) * | 1997-12-18 | 1999-07-12 | Gibbs, Christopher David | Oral care composition |
FR2796844B1 (en) * | 1999-07-27 | 2003-05-23 | Goemar Lab Sa | NEW USE OF HYPOOSMOTIC SALINE SOLUTIONS AND DRUGS BASED ON THESE SOLUTIONS |
US20040120902A1 (en) * | 2001-04-24 | 2004-06-24 | Wernett Patrick Clinton | Fluoride compatible calcium carbonate |
CA2443747A1 (en) * | 2001-04-24 | 2002-10-31 | Specialty Minerals (Michigan) Inc. | Fluoride compatible calcium carbonate |
JP2009520829A (en) * | 2005-12-20 | 2009-05-28 | ザ プロクター アンド ギャンブル カンパニー | Oral care composition comprising zinc and phytate |
US20080274062A1 (en) * | 2007-05-02 | 2008-11-06 | Chantal Bergeron | Glycyrrhizic acid compounds as a foamer in chemically-derived surfactant-free dentifrice |
AU2009241468A1 (en) * | 2008-04-28 | 2009-11-05 | The Procter & Gamble Company | Oral care compositions |
CN101292943B (en) * | 2008-06-20 | 2010-04-14 | 陕西太和科技股份有限公司 | Nanometer zinc oxide toothpaste |
CN101690699A (en) * | 2009-09-29 | 2010-04-07 | 广东名臣有限公司 | Teeth-cleaning whitening toothpaste composition |
CN103764102B (en) * | 2011-09-08 | 2018-05-29 | 荷兰联合利华有限公司 | Remineralization of teeth denfifrice |
-
2014
- 2014-05-15 WO PCT/CN2014/077529 patent/WO2015172344A1/en active Application Filing
-
2015
- 2015-04-28 WO PCT/CN2015/077634 patent/WO2015172651A1/en active Application Filing
- 2015-04-28 CN CN201580024067.1A patent/CN106456462A/en active Pending
- 2015-04-28 BR BR112016025826-6A patent/BR112016025826B1/en active IP Right Grant
- 2015-04-28 EP EP15792524.9A patent/EP3142630A1/en not_active Withdrawn
- 2015-04-28 CA CA2948196A patent/CA2948196C/en active Active
- 2015-04-28 AU AU2015258611A patent/AU2015258611B2/en active Active
- 2015-04-28 MX MX2016015017A patent/MX363625B/en unknown
- 2015-05-15 AR ARP150101528A patent/AR100467A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP3142630A1 (en) | 2017-03-22 |
WO2015172651A1 (en) | 2015-11-19 |
AR100467A1 (en) | 2016-10-05 |
AU2015258611B2 (en) | 2018-02-15 |
WO2015172344A1 (en) | 2015-11-19 |
MX2016015017A (en) | 2017-08-10 |
AU2015258611A1 (en) | 2016-11-17 |
CA2948196A1 (en) | 2015-11-19 |
BR112016025826B1 (en) | 2020-12-08 |
MX363625B (en) | 2019-03-28 |
CN106456462A (en) | 2017-02-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10226414B2 (en) | Dentifrice compositions with improved fluoride stability | |
US10039697B2 (en) | Dentifrice compositions having improved fluoride ion stability or fluoride uptake | |
US10130569B2 (en) | Dentifrice compositions having dental plaque mitigation or improved fluoride uptake | |
CA2948196C (en) | Dentifrice compositions with improved fluoride stability | |
EP3373891B1 (en) | Dentifrice compositions with improved fluoride stability | |
US20170135935A1 (en) | Dentifrice Compositions With Improved Consumer Experience | |
US10213370B2 (en) | Dentifrice compositions with improved fluoride stability |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request |
Effective date: 20161107 |